Alpha Cognition receives European patent for Alzheimer's drug Zunveyl

Go back to Alpha Cognition receives European patent for Alzheimer's drug Zunveyl
(NASDAQ: ACOG) Delayed: 8.83 -0.02 (0.23%)
Previous Close $8.85    52 Week High
Open $8.88    52 Week Low
Day High $9.21    P/E N/A 
Day Low $8.77    EPS
Volume 61,881